SEC Form S-3ASR filed by Incyte Corp.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
THE SECURITIES ACT OF 1933
|
Delaware
(State or other jurisdiction of
incorporation or organization) |
| |
94-3136539
(I.R.S. Employer
Identification Number) |
|
Wilmington, Delaware 19803
(302) 498-6700
President and Chief Executive Officer
Incyte Corporation
1801 Augustine Cut-Off
Wilmington, Delaware 19803
(302) 498-6700
David E Lillevand
Pillsbury Winthrop Shaw Pittman LLP
Four Embarcadero Center, 22nd Floor
San Francisco, CA 94111
Telephone: (415) 983-1000
|
Large accelerated filer
☒
|
| |
Accelerated filer
☐
|
|
|
Non-accelerated filer
☐
|
| |
Smaller reporting company
☐
|
|
| | | |
Emerging growth company
☐
|
|
![[MISSING IMAGE: lg_incytenew-4c.jpg]](https://www.sec.gov/Archives/edgar/data/0000879169/000110465925010997/lg_incytenew-4c.jpg)
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 4 | | | |
| | | | 4 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 7 | | | |
| | | | 8 | | |
| | |
Shares Beneficially
Owned Prior to Offering(1) |
| |
Shares
Being Offered |
| |
Shares Beneficially
Owned After Offering |
| |||||||||||||||||||||
Name and Address
|
| |
Number
|
| |
Percent
|
| |
Number
|
| |
Number
|
| |
Percent
|
| |||||||||||||||
Baker Bros. Advisors LP(2)
|
| | | | 30,487,103 | | | | | | 15.8% | | | | | | 30,487,103 | | | | | | — | | | | | | — | | |
|
SEC registration fee
|
| | | $ | 345,680.64 | | |
|
Legal fees and expenses
|
| | | | * | | |
|
Accounting fees and expenses
|
| | | | * | | |
|
Printing and miscellaneous fees and expenses
|
| | | | * | | |
| | | | | $ | * | | |
|
Exhibit
No. |
| |
Description
|
|
| 4.1 | | | Registration Rights Agreement, dated as of February 12, 2016, between the Registrant and 667, L.P., Baker Brothers Life Sciences, L.P. and 14159, L.P. (incorporated by reference to Exhibit 10.28 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2015). | |
| 5.1 | | | | |
| 23.1 | | | | |
| 23.2 | | | | |
| 24.1 | | | | |
| 107.1 | | | |
Chairman, President, and Chief Executive Officer
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Hervé Hoppenot
Hervé Hoppenot
|
| | President and Chief Executive Officer (Principal Executive Officer) and Chairman | | |
February 10, 2025
|
|
|
/s/ Christiana Stamoulis
Christiana Stamoulis
|
| | Executive Vice President and Chief Financial Officer (Principal Financial Officer) | | |
February 10, 2025
|
|
|
/s/ Thomas Tray
Thomas Tray
|
| | Vice President and Chief Accounting Officer (Principal Accounting Officer) | | |
February 10, 2025
|
|
|
/s/ Julian C. Baker
Julian C. Baker
|
| | Director | | |
February 10, 2025
|
|
|
/s/ Jean-Jacques Bienaimé
Jean-Jacques Bienaimé
|
| | Director | | |
February 10, 2025
|
|
|
/s/ Otis W. Brawley
Otis W. Brawley
|
| | Director | | |
February 10, 2025
|
|
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ Paul J. Clancy
Paul J. Clancy
|
| | Director | | |
February 10, 2025
|
|
|
/s/ Jacqualyn A. Fouse
Jacqualyn A. Fouse
|
| | Director | | |
February 10, 2025
|
|
|
/s/ Edmund P. Harrigan
Edmund P. Harrigan
|
| | Director | | |
February 10, 2025
|
|
|
/s/ Katherine A. High
Katherine A. High
|
| | Director | | |
February 10, 2025
|
|
|
/s/ Susanne Schaffert
Susanne Schaffert
|
| | Director | | |
February 10, 2025
|
|